Skip to main content
Radiation Oncology (London, England) logoLink to Radiation Oncology (London, England)
. 2023 May 5;18:75. doi: 10.1186/s13014-023-02245-0

Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study

Li Jiang 1,2, Jie Zhu 2, Xue Chen 1,2, Yi Wang 2, Lei Wu 2, Gang Wan 2, Yongtao Han 3, Xuefeng Leng 3, Lin Peng 3,✉, Qifeng Wang 2,✉
PMCID: PMC10163754  PMID: 37147731

Radiation Oncology (2022) 17:218

10.1186/s13014-022-02190-4

After publication of this article [1], the authors reported that in this article Li Jiang was incorrectly denoted as a corresponding author.

The original article [1] has been corrected.

Footnotes

The online version of the original article can be found at 10.1186/s13014-022-02190-4.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Li Jiang, Email: jane.lili@foxmail.com.

Jie Zhu, Email: zhujiethu@foxmail.com.

Xue Chen, Email: Cxx_Shirley@163.com.

Yi Wang, Email: wangleo@126.com.

Lei Wu, Email: wuleidoctor@163.com.

Gang Wan, Email: 821170001@qq.com.

Yongtao Han, Email: hanyongt@aliyun.com.

Xuefeng Leng, Email: leng724@163.com.

Lin Peng, Email: penglinms@126.com.

Qifeng Wang, Email: littlecancer@163.com.

References

  • 1.Jiang L, Zhu J, Chen X, Wang Y, Wu L, Wan G, et al. Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study. Radiat Oncol. 2022;17:218. 10.1186/s13014-022-02190-4 [DOI] [PMC free article] [PubMed]

Articles from Radiation Oncology (London, England) are provided here courtesy of BMC

RESOURCES